Rapporto sull’analisi delle dimensioni e delle quote del mercato dei vaccini veterinari | Previsioni 2031

  • Report Code : TIPRE00003539
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 181
Buy Now

Si prevede che il mercato dei vaccini veterinari raggiungerà i 15.536,38 milioni di dollari entro il 2028 rispetto ai 9.984,65 milioni di dollari del 2021; si stima registrerà un CAGR del 6,5% dal 2021 al 2028.

I vaccini veterinari sono prodotti parenterali utilizzati per prevenire malattie infettive causate da vari agenti patogeni. Questi vaccini proteggono gli animali da una varietà di malattie potenzialmente letali. I vaccini veterinari svolgono un ruolo fondamentale nel garantire la longevità, la buona salute e la produzione complessiva di animali domestici e bestiame in modo economicamente vantaggioso. I vaccini veterinari sono classificati come vaccini inattivati, vivi attenuati, tossoidi e ricombinanti. I fattori chiave che guidano la crescita del mercato sono la crescente incidenza delle malattie zoonotiche e la crescente prevalenza di malattie e infezioni di origine alimentare. Tuttavia, le rigide norme governative relative all’uso dei vaccini veterinari stanno ostacolando la crescita del mercato. Il mercato dei vaccini veterinari, per regione, è segmentato in Nord America, Europa, Asia Pacifico (APAC), Medio Oriente e Africa (MEA) e America meridionale e centrale (SAM). Il Nord America domina il mercato globale grazie alla maggiore adozione di animali da compagnia, all'aumento del consumo di carne e latte e alla maggiore comprensione dei benefici delle vaccinazioni animali.

Approfondimenti strategici< br>

Regioni redditizie per il mercato dei vaccini veterinari


Approfondimenti sul mercato

In aumento Incidenza delle malattie zoonotiche

Gli animali trasportano batteri, virus, parassiti e funghi pericolosi verso le persone, provocando malattie. Tali malattie sono conosciute come malattie zoonotiche o zoonosi. L'effetto clinico delle malattie zoonotiche può variare da lieve a grave e talvolta portare alla morte. Le malattie zoonotiche sono onnipresenti nel mondo. Secondo le proiezioni del Center for Disease Control (CDC), >6 su 10 malattie infettive esistenti nell'uomo possono diffondersi attraverso gli animali, e 3 su 4 malattie infettive nuove o future nell'uomo proverranno da animali. Inoltre, nel 2016, almeno 55.000 individui sono morti di rabbia in Asia e Africa.

Negli ultimi decenni, diverse nuove malattie infettive umane che hanno causato virus, come il virus Ebola, il virus del Nilo occidentale virus, il virus dell’immunodeficienza umana (HIV), il virus Nipah e le infezioni da Hantavirus si sono evoluti da serbatoi animali. Epidemie, come la sindrome respiratoria acuta grave (SARS) e l’influenza aviaria, hanno sottolineato il potenziale dei germi provenienti dai serbatoi animali di adattarsi agli ospiti umani. Più di tre quarti delle malattie umane nuove, emergenti o riemergenti all’inizio del 21° secolo sono causate da agenti patogeni derivati da animali o prodotti di origine animale. Secondo l’OMS, circa il 60% delle nuove malattie infettive identificate a livello globale sono zoonosi e ogni anno oltre 1 miliardo di casi di malattia e milioni di decessi si verificano a causa delle zoonosi. Negli ultimi tre decenni sono state riscontrate oltre 30 nuove infezioni umane e il 75% di queste ha origine da animali. Pertanto, le malattie zoonotiche emergenti e riemergenti spingono la domanda di salute animale. Pertanto, le aziende producono farmaci e vaccini migliorati per aiutare i proprietari di animali o altre parti interessate a mantenere la salute generale degli animali. Pertanto, la crescita dell'incidenza delle malattie zoonotiche stimola la crescita del mercato dei vaccini veterinari.

Approfondimenti basati sul tipo di vaccino

Il mercato globale dei vaccini veterinari , in base al tipo di vaccino, è suddiviso in vaccini per il bestiame, vaccini per animali da compagnia e altri. È probabile che il segmento dei vaccini per bestiame deterrà la quota di mercato maggiore nel 2021. Tuttavia, si prevede che il segmento degli animali da compagnia registrerà il CAGR più elevato, pari al 7,0% durante il periodo di previsione.

Veterinaria Mercato dei vaccini, per tipo di vaccino: 2021 e 2028

Approfondimenti basati sulla tecnologia

Il mercato globale dei vaccini veterinari, basato sulla tecnologia, è segmentato in vaccini vivi attenuati, vaccini inattivati, vaccini tossoidi , vaccini ricombinanti, vaccini coniugati e altri. Nel 2021, è probabile che il segmento dei vaccini vivi attenuati deterrà la quota di mercato maggiore. Tuttavia, si prevede che il segmento dei vaccini inattivati crescerà al CAGR più elevato dal 2021 al 2028.

Gli operatori del mercato dei vaccini veterinari adottano strategie organiche, come il lancio e l'espansione del prodotto, per espandersi la loro presenza e il portafoglio di prodotti in tutto il mondo e per soddisfare la crescente domanda.

Geografia

Geograficamente, il mercato dei vaccini veterinari è segmentato in Nord America (Stati Uniti, Canada , e Messico), Europa (Francia, Germania, Regno Unito, Spagna, Italia e resto d'Europa), Asia Pacifico (Cina, India, Giappone, Australia, Corea del Sud e resto dell'APAC), Medio Oriente e ; Africa (Arabia Saudita, Emirati Arabi Uniti, Sud Africa e resto del MEA) e America meridionale e centrale (Brasile, Argentina e il resto del sistema SCAM).

Impatti del COVID

I paesi europei sono fortemente colpiti dalla pandemia di COVID-19. Per controllare l’epidemia del virus il governo ha imposto varie restrizioni. Ciò ha portato a interruzioni, limitazioni, sfide e cambiamenti in ogni settore di ogni industria. Allo stesso modo, anche l’industria dei vaccini animali è stata colpita dalla pandemia. Ad esempio, le organizzazioni veterinarie all’estero hanno raccomandato di limitare la cura dei pazienti animali agli animali gravemente malati e alle emergenze. Inoltre, i lockdown hanno portato a riprogrammare gli esami di controllo annuali e le procedure di vaccinazione elettiva.

Tuttavia, diversi attori chiave hanno assicurato la fornitura di vaccini animali mentre le istituzioni governative di tutto il mondo stanno adottare misure rigorose per mantenere la fornitura ed evitare che i virus zoonotici si diffondano nelle comunità. Tuttavia, l'impatto complessivo del COVID-19 sul mercato dei vaccini animali rimane piuttosto negativo, a causa del calo della domanda poiché le visite veterinarie sono limitate e l'approccio sanitario animale è stato modificato per fornire assistenza ai casi di emergenza e agli animali critici.

Profili aziendali

  • Boehringer Ingelheim International GmbH
  • MERCK
  • Zoetis Services LLC
  • Elanco
  • Vetoquinol
  • Ceva
  • Virbac
  • NEOGEN Corporation
  • Biovac
  • < li>ImmuCell Corporation    
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are Veterinary Vaccines?

A Veterinary Vaccines is a sterile glass or plastic test tube with a stopper that creates a vacuum inside the tube so that a preset volume of liquid can be depicted. The Veterinary Vaccines prevents needle stick damage by preventing needles from coming in human contact and thus, adulteration. A double-pointed needle is fitted to a plastic tubular adapter in the vacuum blood collecting tube. Double pointed needles are available in numerous gauge sizes. The needle's length varies from 1 to 1 1/2 inches. Additional elements may be present in Veterinary Vacciness, which are used to preserve blood for treatment in a medical laboratory.

What are the driving factors for the Veterinary Vaccines market across the globe?

Key factors that are driving growth of the market are increasing incidence of zoonotic diseases and rising prevalence foodborne diseases and infections propel the market growth. However, strict government rules related to the usage of veterinary vaccines hamper the growth of the market.

What will be the CAGR of Veterinary Vaccines market?

The Veterinary Vaccines market is anticipated to grow around 6.5% CAGR amid the forecast period 2021-2028.

Who are the key players in the Veterinary Vaccines market?

Boehringer Ingelheim International GmbH and Zoetis Inc., are the key players in the Veterinary Vaccines market.

Which segment among Veterinary Vaccines market provides the most opportunity for growth?

Livestock vaccines segment market provides the most opportunity for growth.

The List of Companies - Veterinary Vaccines Market

  1. Boehringer Ingelheim International GmbH
  2. MERCK
  3. Zoetis Services LLC
  4. Elanco
  5. Vetoquinol
  6. Ceva
  7. Virbac
  8. NEOGEN Corporation
  9. Biovac
  10. ImmuCell Corporation

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports